Clinical Trial: An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Multi-center, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Different Doses of Dexamethasone for Management of Immune Thrombocytopenia (ITP)

Brief Summary: The project was undertaking by Qilu Hospital of Shandong University and other 7 well-known hospitals in China. In order to report the efficacy and safety of different dose dexamethasone in treating the immune thrombocytopenia (ITP).